methenamine 162 MG / sodium salicylate 162.5 MG Oral Tablet
RxNorm concept 1489932, clinical drug (scd).
- RxCUI
- 1489932
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1489932 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- methenamine 162 MG (SCDC, consists of)
- sodium salicylate 162.5 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- methenamine 162 MG / sodium salicylate 162.5 MG Oral Tablet [Cystex] (SBD, has tradename)
- methenamine 162 MG / sodium salicylate 162.5 MG Oral Tablet [Azo Urinary Tract Defense] (SBD, has tradename)
Linked data
NDCs
- 00363127748
- 00363440424
- 10956076324
- 11822489204
- 36800031424
- 41250055724
- 46122062262
- 51316077748
- 57237033242
- 57237033281
- 63868018724
- 68016000324
- 69842031424
- 72090006501
- 73436122102
- 73712080412
- 83324019824
- 84324004101
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1489932 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1489932 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1489932. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.